- £102.93m
- £97.68m
- £12.97m
Annual balance sheet for Bioventix, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | UAS | UAS | UAS | UAS | UAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 6.13 | 5.72 | 6 | 5.08 | 5.26 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.764 | 1.17 | 1.55 | 1.06 | 1.45 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 11.8 | 12.1 | 12.8 | 12 | 12 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.694 | 0.576 | 0.478 | 0.404 | 0.43 |
| Long Term Investments | |||||
| Total Assets | 13.1 | 13.3 | 13.7 | 12.9 | 12.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.25 | 1.2 | 1.73 | 1.31 | 1.4 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 1.3 | 1.22 | 1.73 | 1.31 | 1.41 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 11.8 | 12.1 | 12 | 11.6 | 11.4 |
| Total Liabilities & Shareholders' Equity | 13.1 | 13.3 | 13.7 | 12.9 | 12.8 |
| Total Common Shares Outstanding |